Vanguard Group’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $387M | Buy |
2,714,746
+89,755
| +3% | +$12M | 0.01% | 1204 |
|
|
2025
Q3 | $315M | Sell |
2,624,991
-33,506
| -1% | -$4.25M | ﹤0.01% | 1301 |
|
|
2025
Q2 | $351M | Buy |
2,658,497
+16,222
| +0.6% | +$2.2M | 0.01% | 1227 |
|
|
2025
Q1 | $367M | Sell |
2,642,275
-39,790
| -1% | -$6.18M | 0.01% | 1162 |
|
|
2024
Q4 | $416M | Buy |
2,682,065
+17,805
| +0.7% | +$3.01M | 0.01% | 1144 |
|
|
2024
Q3 | $485M | Buy |
2,664,260
+94,646
| +4% | +$14M | 0.01% | 1059 |
|
|
2024
Q2 | $305M | Buy |
2,569,614
+116,894
| +5% | +$12.3M | 0.01% | 1253 |
|
|
2024
Q1 | $263M | Buy |
2,452,720
+11,991
| +0.5% | +$1.19M | 0.01% | 1354 |
|
|
2023
Q4 | $243M | Buy |
2,440,729
+315,103
| +15% | +$30.8M | 0.01% | 1394 |
|
|
2023
Q3 | $253M | Sell |
2,125,626
-4,211
| -0.2% | -$628K | 0.01% | 1317 |
|
|
2023
Q2 | $380M | Sell |
2,129,837
-4,201
| -0.2% | -$771K | 0.01% | 1095 |
|
|
2023
Q1 | $352M | Buy |
2,134,038
+29,866
| +1% | +$5.14M | 0.01% | 1112 |
|
|
2022
Q4 | $331M | Buy |
2,104,172
+41,967
| +2% | +$6.39M | 0.01% | 1113 |
|
|
2022
Q3 | $311M | Sell |
2,062,205
-14,776
| -0.7% | -$2.46M | 0.01% | 1114 |
|
|
2022
Q2 | $341M | Sell |
2,076,981
-45,123
| -2% | -$8.69M | 0.01% | 1086 |
|
|
2022
Q1 | $472M | Buy |
2,122,104
+171,851
| +9% | +$38.5M | 0.01% | 1009 |
|
|
2021
Q4 | $463M | Buy |
1,950,253
+57,417
| +3% | +$13.4M | 0.01% | 1047 |
|
|
2021
Q3 | $442M | Buy |
1,892,836
+33,726
| +2% | +$7.07M | 0.01% | 1053 |
|
|
2021
Q2 | $383M | Buy |
1,859,110
+12,895
| +0.7% | +$2.65M | 0.01% | 1170 |
|
|
2021
Q1 | $379M | Buy |
1,846,215
+40,853
| +2% | +$8.63M | 0.01% | 1134 |
|
|
2020
Q4 | $387M | Buy |
1,805,362
+36,967
| +2% | +$7.17M | 0.01% | 1031 |
|
|
2020
Q3 | $323M | Sell |
1,768,395
-68,923
| -4% | -$13M | 0.01% | 991 |
|
|
2020
Q2 | $339M | Sell |
1,837,318
-11,852
| -0.6% | -$2.35M | 0.01% | 952 |
|
|
2020
Q1 | $373M | Buy |
1,849,170
+18,213
| +1% | +$3.51M | 0.02% | 798 |
|
|
2019
Q4 | $343M | Buy |
1,830,957
+48,957
| +3% | +$8.43M | 0.01% | 1041 |
|
|
2019
Q3 | $284M | Buy |
1,782,000
+26,106
| +1% | +$5.2M | 0.01% | 1123 |
|
|
2019
Q2 | $442M | Sell |
1,755,894
-29,863
| -2% | -$6.92M | 0.02% | 868 |
|
|
2019
Q1 | $427M | Buy |
1,785,757
+12,800
| +0.7% | +$3.07M | 0.02% | 867 |
|
|
2018
Q4 | $407M | Buy |
1,772,957
+289,456
| +20% | +$71.4M | 0.02% | 809 |
|
|
2018
Q3 | $419M | Buy |
1,483,501
+158,798
| +12% | +$46.5M | 0.02% | 889 |
|
|
2018
Q2 | $389M | Buy |
1,324,703
+16,603
| +1% | +$4.54M | 0.02% | 913 |
|
|
2018
Q1 | $330M | Sell |
1,308,100
-85,232
| -6% | -$20M | 0.01% | 972 |
|
|
2017
Q4 | $301M | Buy |
1,393,332
+24,031
| +2% | +$4.86M | 0.01% | 1021 |
|
|
2017
Q3 | $254M | Buy |
1,369,301
+65,019
| +5% | +$11.3M | 0.01% | 1098 |
|
|
2017
Q2 | $225M | Buy |
1,304,282
+183,133
| +16% | +$29.4M | 0.01% | 1150 |
|
|
2017
Q1 | $171M | Sell |
1,121,149
-145,576
| -11% | -$21.3M | 0.01% | 1324 |
|
|
2016
Q4 | $187M | Sell |
1,266,725
-4,204
| -0.3% | -$608K | 0.01% | 1215 |
|
|
2016
Q3 | $161M | Buy |
1,270,929
+3,611
| +0.3% | +$435K | 0.01% | 1260 |
|
|
2016
Q2 | $143M | Sell |
1,267,318
-33,519
| -3% | -$3.48M | 0.01% | 1260 |
|
|
2016
Q1 | $135M | Sell |
1,300,837
-4,456
| -0.3% | -$426K | 0.01% | 1264 |
|
|
2015
Q4 | $147M | Buy |
1,305,293
+48,453
| +4% | +$5.35M | 0.01% | 1197 |
|
|
2015
Q3 | $138M | Buy |
1,256,840
+139,169
| +12% | +$14.9M | 0.01% | 1214 |
|
|
2015
Q2 | $107M | Buy |
1,117,671
+138,397
| +14% | +$12.9M | 0.01% | 1466 |
|
|
2015
Q1 | $91.2M | Buy |
979,274
+38,880
| +4% | +$3.4M | 0.01% | 1561 |
|
|
2014
Q4 | $77M | Buy |
940,394
+20,246
| +2% | +$1.55M | 0.01% | 1592 |
|
|
2014
Q3 | $59.1M | Buy |
920,148
+7,170
| +0.8% | +$439K | ﹤0.01% | 1712 |
|
|
2014
Q2 | $55.5M | Buy |
912,978
+11,719
| +1% | +$692K | ﹤0.01% | 1781 |
|
|
2014
Q1 | $54M | Buy |
901,259
+49,529
| +6% | +$3.05M | ﹤0.01% | 1764 |
|
|
2013
Q4 | $54.3M | Buy |
851,730
+34,641
| +4% | +$2.23M | ﹤0.01% | 1736 |
|
|
2013
Q3 | $55.5M | Sell |
817,089
-78,033
| -9% | -$5.57M | 0.01% | 1657 |
|
|
2013
Q2 | $64.5M | Buy |
+895,122
| New | +$59.2M | 0.01% | 1455 |
|
Other funds holding ICUI
RRAM
Vanguard Group's ICUI Position: Q4 2025 in Review
Vanguard Group increased its ICU Medical (ICUI) stake by 3.4% in Q4 2025, buying an estimated $12M and bringing the position to 2,714,746 shares worth $387M. The position accounts for 0.01% of the portfolio, ranked #1204.
Vanguard Group first reported a position in ICUI in Q2 2013 and has held it in 51 quarters since. The position peaked at $485M in Q3 2024. 291 funds tracked by Wall St. Rank hold ICUI as of Q4 2025.
- Vanguard Group held 2,714,746 shares of ICU Medical worth $387M as of Q4 2025.
- Vanguard Group bought 89,755 ICU Medical shares in Q4 2025, an estimated $12M.
- ICU Medical made up 0.01% of Vanguard Group's portfolio in Q4 2025, its #1204 holding.
- Vanguard Group first reported a position in ICU Medical in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's ICU Medical position peaked at $485M in Q3 2024.
- 291 funds tracked by Wall St. Rank held ICU Medical as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.